François Tranquart

Learn More
The recent introduction of tissue harmonic imaging could resolve the problems related to ultrasound in technically difficult patients by providing a marked improvement in image quality. Tissue harmonics are generated during the transmit phase of the pulse-echo cycle, that is, while the transmitted pulse propagates through tissue. Tissue harmonic images are(More)
Significant advances have been recently introduced into various fields of technology, taking advantage of the use of new piezoelectric materials and the large diffusion of broadband transducers. Various types of modulation may be applied to the pulse characteristics, using single pulse, multipulse or multiline techniques, and resulting in improved spatial(More)
Ultrasound contrast imaging techniques represent a real opportunity to improve efficiency in the preclinical drug discovery and development process. Ultrasound contrast agents (UCAs) combined with specific ultrasound contrast detection modes provide real-time, high spatial resolution of both organ and lesion blood perfusion, the so-called dynamic(More)
OBJECTIVES To evaluate BR55, a new VEGFR2-specific ultrasound contrast agent, for imaging prostate tumors in an orthotopic model in the rat. MATERIALS AND METHODS Rat prostate adenocarcinoma were established by injection of G Dunning R-3327 tumor cells in one lobe of the prostate of Copenhagen rats. Imaging experiments were performed with BR55, SonoVue,(More)
PURPOSE To develop and test a molecular imaging approach that uses ultrasonography (US) and a clinically translatable dual-targeted (P- and E-selectin) contrast agent (MBSelectin) in the quantification of inflammation at the molecular level and to quantitatively correlate selectin-targeted US with fluorodeoxyglucose (FDG) combined positron emission(More)
UNLABELLED The purpose of this study was to assess the accuracy of Cadence Contrast Pulse Sequencing (Siemens-Acuson, CA) method with injection of SonoVue (Bracco Imaging SpA, Italy) for the detection and characterisation of focal liver lesions in comparison with a reference modality during routine use. METHODS 138 consecutive patients (62 women, 76 men;(More)
Conventional ultrasonography of the kidney is faced by limitations due to the poor contrast of B-mode imaging for parenchymal disease and limited sensitivity of color Doppler for the detection of intracortical capillaries and deep pedicular vessels. Ultrasound contrast agents (USCAs) overcome these limitations, allowing the development of new applications(More)
OBJECTIVES Ultrasound molecular imaging is increasingly used in preclinical studies to measure the expression of vascular markers during inflammation process. In this context, a new ultrasound contrast agent functionalized with a recombinant P-selectin glycoprotein ligand-1 analogue (rPSGL-Ig) was developed (MBrPSGL-Ig). This agent was assayed in vitro and(More)
Introduction: Characterization of focal liver lesions is presently the most important application of Contrast-Enhanced Ultrasound in Europe [1]. After a bolus injection of contrast agent, such a characterization is commonly guided by known Dynamic Vascular Patterns (DVP) of lesions with respect to surrounding healthy parenchyma. Figure 1(a) illustrates(More)